Behandling i 16 uger resulterede i lavere vedvarende virologisk respons (65%) end behandling i 24 uger (76%) (p < 0, 0001).
Overall treatment for 16 weeks resulted in lower sustained viral response (65%) than treatment for 24 weeks (76%) (p < 0.0001).